Skip to content
Narconon Results -- Drug-Free Lives
Narrow screen resolution Wide screen resolution Increase font size Decrease font size Default font size default color
 
You are here: Home arrow Science & Research arrow Reduction of Drug Residues
Reduction of Drug Residues | Print |  E-mail

The Narconon® New Life Detoxification Program

Excerpted from “Reduction of Drug Residues: Applications in Drug Rehabilitation,” a presentation to the 123rd Annual Meeting of the American Public Health Association. Authors: Megan Shields, M.D.; F. Tennant, M.D., Dr. P.H.; Shelley Beckmann, Ph.D.; and R. Michael Wisner.


It is increasingly evident that the accumulation of drug residues and their lipophilic metabolites in the body plays a role in drug addiction. Such residues are associated with persistent symptoms and their mobilization from body stores into blood correlates with drug craving.

A detoxification method developed by L. Ron Hubbard was specifically targeted at reducing levels of fat-stored chemical residues in the body and thereby alleviating the long-term effects of such compounds. We were interested in determining whether drugs were eliminated during this program and, if so, what types of symptom changes occurred as a consequence.

The concentration of drug metabolites in both sweat and urine was measured in eight clients who had been actively using drugs prior to treatment with Mr. Hubbard’s program. Treatment occurred at the Narconon drug rehabilitation center in Los Angeles.

Cocaine, amphetamine and benzodiazepine metabolites were detected by fluorescent immunoassay in both sweat and urine of these clients. Following start of treatment, metabolite concentration increased in either sweat or urine in five cases. In two cases the level of drug was below detection prior to treatment but became detectable while doing the detoxification program. Drugs continued to be eliminated for up to five weeks.

A separate series of 249 clients with a history of drug abuse rated the severity of their symptoms before and after treatment with Mr. Hubbard’s program. Prior to treatment, their chief symptomatic complaints included fatigue, irritability, depression, intolerance of stress, reduced attention span and decreased mental acuity. These same symptoms were dominant in those who had ceased active drug abuse over a year prior to treatment. Following treatment, both past and current users reported marked improvements in symptoms with most returning to normal range. This detoxification program represents a vital innovation in drug rehabilitation: an approach aimed at a long-term reduction of the predisposition for drug abuse.

view entire document